183 related articles for article (PubMed ID: 9188620)
1. Immunogenicity of a contiguous T-B synthetic epitope of the A/PR/8/34 influenza virus.
Brumeanu TD; Casares S; Bot A; Bot S; Bona CA
J Virol; 1997 Jul; 71(7):5473-80. PubMed ID: 9188620
[TBL] [Abstract][Full Text] [Related]
2. Protective immunity elicited by vaccination with DNA encoding for a B cell and a T cell epitope of the A/PR/8/34 influenza virus.
Casares S; Brumeanu TD; Bot A; Bona CA
Viral Immunol; 1997; 10(3):129-36. PubMed ID: 9344335
[TBL] [Abstract][Full Text] [Related]
3. Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets.
Rosendahl Huber SK; Camps MG; Jacobi RH; Mouthaan J; van Dijken H; van Beek J; Ossendorp F; de Jonge J
PLoS One; 2015; 10(6):e0127969. PubMed ID: 26046664
[TBL] [Abstract][Full Text] [Related]
4. Specificity-based negative selection of autoreactive B cells during memory formation.
Guay HM; Panarey L; Reed AJ; Caton AJ
J Immunol; 2004 Nov; 173(9):5485-94. PubMed ID: 15494496
[TBL] [Abstract][Full Text] [Related]
5. A multivalent minigene vaccine, containing B-cell, cytotoxic T-lymphocyte, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen.
An LL; Whitton JL
J Virol; 1997 Mar; 71(3):2292-302. PubMed ID: 9032365
[TBL] [Abstract][Full Text] [Related]
6. Protein Vaccination Directs the CD4
Rattan A; Richards KA; Knowlden ZAG; Sant AJ
J Virol; 2019 Oct; 93(20):. PubMed ID: 31341045
[TBL] [Abstract][Full Text] [Related]
7. Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination.
Thomson SA; Sherritt MA; Medveczky J; Elliott SL; Moss DJ; Fernando GJ; Brown LE; Suhrbier A
J Immunol; 1998 Feb; 160(4):1717-23. PubMed ID: 9469429
[TBL] [Abstract][Full Text] [Related]
8. T cell epitope engineering: an avian H7N9 influenza vaccine strategy for pandemic preparedness and response.
Moise L; M Biron B; Boyle CM; Kurt Yilmaz N; Jang H; Schiffer C; M Ross T; Martin WD; De Groot AS
Hum Vaccin Immunother; 2018; 14(9):2203-2207. PubMed ID: 30015562
[TBL] [Abstract][Full Text] [Related]
9. A human CD4+ T cell epitope in the influenza hemagglutinin is cross-reactive to influenza A virus subtypes and to influenza B virus.
Babon JA; Cruz J; Ennis FA; Yin L; Terajima M
J Virol; 2012 Sep; 86(17):9233-43. PubMed ID: 22718815
[TBL] [Abstract][Full Text] [Related]
10. Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus.
Quan FS; Huang C; Compans RW; Kang SM
J Virol; 2007 Apr; 81(7):3514-24. PubMed ID: 17251294
[TBL] [Abstract][Full Text] [Related]
11. Complement C3 Plays a Key Role in Inducing Humoral and Cellular Immune Responses to Influenza Virus Strain-Specific Hemagglutinin-Based or Cross-Protective M2 Extracellular Domain-Based Vaccination.
Kim YJ; Kim KH; Ko EJ; Kim MC; Lee YN; Jung YJ; Lee YT; Kwon YM; Song JM; Kang SM
J Virol; 2018 Oct; 92(20):. PubMed ID: 30068650
[TBL] [Abstract][Full Text] [Related]
12. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
J Virol; 2017 May; 91(9):. PubMed ID: 28179535
[TBL] [Abstract][Full Text] [Related]
13. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.
Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC
J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of novel Dengue virus epitopes identified by bioinformatic analysis.
Sánchez-Burgos G; Ramos-Castañeda J; Cedillo-Rivera R; Dumonteil E
Virus Res; 2010 Oct; 153(1):113-20. PubMed ID: 20638434
[TBL] [Abstract][Full Text] [Related]
15. Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza.
Deliyannis G; Kedzierska K; Lau YF; Zeng W; Turner SJ; Jackson DC; Brown LE
Eur J Immunol; 2006 Mar; 36(3):770-8. PubMed ID: 16435281
[TBL] [Abstract][Full Text] [Related]
16. Intranasal immunization of mice against influenza with synthetic peptides anchored to proteosomes.
Levi R; Aboud-Pirak E; Leclerc C; Lowell GH; Arnon R
Vaccine; 1995 Oct; 13(14):1353-9. PubMed ID: 8585293
[TBL] [Abstract][Full Text] [Related]
17. Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene.
Bot A; Antohi S; Bot S; Garcia-Sastre A; Bona C
Int Immunol; 1997 Nov; 9(11):1641-50. PubMed ID: 9418125
[TBL] [Abstract][Full Text] [Related]
18. A Novel Vaccine Strategy to Overcome Poor Immunogenicity of Avian Influenza Vaccines through Mobilization of Memory CD4 T Cells Established by Seasonal Influenza.
DiPiazza AT; Fan S; Rattan A; DeDiego ML; Chaves F; Neumann G; Kawaoka Y; Sant AJ
J Immunol; 2019 Sep; 203(6):1502-1508. PubMed ID: 31399519
[TBL] [Abstract][Full Text] [Related]
19. Conserved stem fragment from H3 influenza hemagglutinin elicits cross-clade neutralizing antibodies through stalk-targeted blocking of conformational change during membrane fusion.
Gong X; Yin H; Shi Y; Guan S; He X; Yang L; Yu Y; Kuai Z; Jiang C; Kong W; Wang S; Shan Y
Immunol Lett; 2016 Apr; 172():11-20. PubMed ID: 26875772
[TBL] [Abstract][Full Text] [Related]
20. A retro-inverso peptide analogue of influenza virus hemagglutinin B-cell epitope 91-108 induces a strong mucosal and systemic immune response and confers protection in mice after intranasal immunization.
Ben-Yedidia T; Beignon AS; Partidos CD; Muller S; Arnon R
Mol Immunol; 2002 Oct; 39(5-6):323-31. PubMed ID: 12220890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]